Ying Fan
- Cancer Research top 2%
- Breast Cancer Treatment Studies 46
- Cancer Genomics and Diagnostics 11
- Oncology top 2%
- Cancer Treatment and Pharmacology 48
- HER2/EGFR in Cancer Research 46
-
- Advanced Breast Cancer Therapies 31
- Lung Cancer Treatments and Mutations 9
- Genetics top 10%
- Estrogen and related hormone effects 9
- Pharmacology top 10%
-
- Breast Lesions and Carcinomas 13
- Journals
- Nature Medicine (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (18 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ying Fan
112 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 697
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 513
- Genetics 93
- Pharmacology 76
Countries citing papers authored by Ying Fan
This map shows the geographic impact of Ying Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Fan more than expected).
Fields of papers citing papers by Ying Fan
This network shows the impact of papers produced by Ying Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Fan. The network helps show where Ying Fan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trialbreakdown → | 2025 | 16 |
| 2 | 2025 | 3 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 61 | |
| 9 | 2018 | 27 | |
| 10 | 2018 | 5 | |
| 11 | 2018 | 34 | |
| 12 | 2018 | 16 | |
| 13 | 2016 | 5 | |
| 14 | 2016 | 27 | |
| 15 | 2015 | 2 | |
| 16 | [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes]. | 2014 | 2 |
| 17 | 2013 | 1 | |
| 18 | 2012 | 40 | |
| 19 | 2012 | 3 | |
| 20 | 2010 | 24 |
About Ying Fan
Ying Fan is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 120 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (48 papers), HER2/EGFR in Cancer Research (46 papers), Breast Cancer Treatment Studies (46 papers), Advanced Breast Cancer Therapies (31 papers), Breast Lesions and Carcinomas (13 papers), Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Estrogen and related hormone effects (9 papers). The work is most often cited by research in Cancer Research (697 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (513 citations). Ying Fan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Fei Ma, Binghe Xu, Pin Zhang, Jiayu Wang, Yang Luo, Ruigang Cai, Qiao Li, Peng Yuan, Shanshan Chen and Qing Li. Their work appears in journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.